Li Su
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Ubiquitin and proteasome pathways 2
- Oncology 7
- Cancer Cells and Metastasis 6
- Co-authors
- Cheng Qian (9 shared papers)Feifei Cheng (4 shared papers)Junjie Shen (7 shared papers)Juanjuan Shan (8 shared papers)Limei Liu (7 shared papers)Chungang Liu (6 shared papers)Zhi Yang (5 shared papers)Jun Chen (5 shared papers)
- Journals
- Cancer Letters (2 papers)Oncotarget (2 papers)Nature Communications (1 paper)Advanced Science (1 paper)Nature Cancer (1 paper)
- Partner nations
- ChinaSpainUnited Kingdom
In The Last Decade
Li Su
29 papers receiving 994 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 315
- Geriatrics and Gerontology 64
- Oncology 230
- Molecular Biology 418
- Pathology and Forensic Medicine 80
Countries citing papers authored by Li Su
This map shows the geographic impact of Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Su more than expected).
Fields of papers citing papers by Li Su
This network shows the impact of papers produced by Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Su. The network helps show where Li Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 285 | |
| 2 | 2016 | 105 | |
| 3 | 2019 | 88 | |
| 4 | 2016 | 85 | |
| 5 | 2011 | 82 | |
| 6 | 2016 | 58 | |
| 7 | 2019 | 55 | |
| 8 | 2016 | 42 | |
| 9 | 2016 | 33 | |
| 10 | 2017 | 29 | |
| 11 | The Chinese medicine, Jianpi Huayu Decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3/Smad7 cascade. | 2017 | 24 |
| 12 | 2018 | 20 | |
| 13 | 2017 | 16 | |
| 14 | 2016 | 11 | |
| 15 | 2024 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2023 | 9 | |
| 18 | 2024 | 7 | |
| 19 | 2014 | 6 | |
| 20 | 2022 | 5 |
About Li Su
Li Su is a scholar working on Molecular Biology, Oncology, Cancer Research, Physiology and Surgery, having authored 30 papers that have together received 999 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Pain Mechanisms and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Genomics and Diagnostics (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Immune cells in cancer (2 papers) and Digestive system and related health (2 papers). The work is most often cited by research in Cancer Research (315 citations), Geriatrics and Gerontology (64 citations), Oncology (230 citations), Molecular Biology (418 citations) and Pathology and Forensic Medicine (80 citations). Li Su has collaborated with scholars based in China, Spain and United Kingdom. Frequent co-authors include Cheng Qian, Feifei Cheng, Junjie Shen, Juanjuan Shan, Limei Liu, Chungang Liu, Zhi Yang, Jun Chen, Chao Yao and Jimin Shao. Their work appears in journals such as Cancer Letters, Oncotarget, Nature Communications, Advanced Science and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.